Payer costs of patients diagnosed with epilepsy.
PURPOSE: To identify the annual cost to a third-party payer of inpatient and outpatient services and prescription drugs for patients diagnosed with epilepsy or convulsions. METHODS: Retrospective study using administrative and claims data from a private insurer in the Northeast United States with &a...
Main Authors: | Griffiths, R, Schrammel, P, Morris, G, Wills, S, Labiner, D, Strauss, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Lippincott Williams and Wilkins
1999
|
Títulos similares
-
Payer costs of patients diagnosed with epilepsy
por: Griffiths, R
Publicado: (1999) -
Factors influencing third party payer costs for allogeneic BMT.
por: Griffiths, R, et al.
Publicado: (1993) -
The global cost of epilepsy: a systematic review and extrapolation
por: Begley, C, et al.
Publicado: (2022) -
Pourquoi Payer ?
por: Mary Ann Bates, et al.
Publicado: (2012-01-01) -
A workplace breast cancer screening program. Costs and components.
por: Schrammel, P, et al.
Publicado: (1998)